Will request for pause in FDA quality metrics plan lead to it being killed as unneeded regulation? epalmer Mon, 04/10/2017 – 11:55 More: Will request for pause in FDA quality metrics plan lead to it being killed as unneeded regulation?
read moreStada’s patience pays off as Cinven, Bain clinch big $5.6B buyout bid esagonowsky Mon, 04/10/2017 – 10:46 More: Stada's patience pays off as Cinven, Bain clinch big .6B buyout bid Source: fierce
read moreAbbVie’s Humira needs a discount, ICER says, warning Lilly, Sanofi to price with care tracy Mon, 04/10/2017 – 10:43 More: AbbVie's Humira needs a discount, ICER says, warning Lilly, Sanofi to price with care Source: fierce
read moreWhen is bad press not so bad? When it’s building a market, AstraZeneca says of its Super Bowl experiment chelfand Mon, 04/10/2017 – 09:43 More: When is bad press not so bad? When it's building a market, AstraZeneca says of
read moreSBRI Healthcare is streaming £2.1 million into supporting the development of innovative technologies that strive to revolutionise primary care and GP services. More: SBRI comp awards £2.1m for primary care projects Source: News
read moreEuropean regulators have ruled that Actelion’s Uptravi can continue to be used as per its prescribing information to treat patients with pulmonary arterial hypertension, a life-threatening condition involving abnormally high blood pressure in the arteries of the lungs. More: EU
read more© 1994 - 2026 B.M. Pharmaceuticals